Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
International Immunopharmacology
|
August 20, 2024
Targeting STAT3 signaling pathway in the treatment of Alzheimer's disease with compounds from natural products
Xiyue Wen, Jinyue Hu
International Immunopharmacology
|
July 30, 2024
TAX1BP1/A20 inhibited TLR2-NF-κB activation to induce tolerant expression of IL-6 in endothelial cells
Mei Yang, Xueting Liu, Manli Jiang, et al.
Oncotargets and Therapy
|
December 17, 2019
VE-822 mediated inhibition of ATR signaling sensitizes chondrosarcoma to cisplatin via reversion of the DNA damage response
Xiao Liang, Qiya Yang, Wanchun Wang, et al.
Immunologic Research
|
May 13, 2005
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
Pablo Iribarren, Ye Zhou, Jinyue Hu, et al.
Pharmaceutical Biology
|
May 21, 2011
Stimulative effects of Polygonum amplexicaule var. sinense on osteoblastic MC3T3-E1 cells
Mei-Xian Xiang, Han-Wen Su, Jinyue Hu, et al.
Oncotarget
|
September 3, 2016
MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis
Yanlin Su, Jie Xiong, Jinyue Hu, et al.
Frontiers in Oncology
|
August 18, 2022
LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
Min Ling, Qing Liu, Yufei Wang, et al.
European Journal of Pharmacology
|
April 13, 2024
Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers
Yufei Wang, Guihua Wang, Wei Xiang, et al.
Inflammation
|
September 30, 2010
TLR4 activation induces nontolerant inflammatory response in endothelial cells
Wenmeng Wang, Minjie Deng, Xueting Liu, et al.
Plos One
|
February 4, 2014
A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells
Jinyue Hu, Guihua Wang, Xueting Liu, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
International Immunopharmacology
|
August 20, 2024
Targeting STAT3 signaling pathway in the treatment of Alzheimer's disease with compounds from natural products
Xiyue Wen, Jinyue Hu
International Immunopharmacology
|
July 30, 2024
TAX1BP1/A20 inhibited TLR2-NF-κB activation to induce tolerant expression of IL-6 in endothelial cells
Mei Yang, Xueting Liu, Manli Jiang, et al.
Oncotargets and Therapy
|
December 17, 2019
VE-822 mediated inhibition of ATR signaling sensitizes chondrosarcoma to cisplatin via reversion of the DNA damage response
Xiao Liang, Qiya Yang, Wanchun Wang, et al.
Immunologic Research
|
May 13, 2005
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
Pablo Iribarren, Ye Zhou, Jinyue Hu, et al.
Pharmaceutical Biology
|
May 21, 2011
Stimulative effects of Polygonum amplexicaule var. sinense on osteoblastic MC3T3-E1 cells
Mei-Xian Xiang, Han-Wen Su, Jinyue Hu, et al.
Oncotarget
|
September 3, 2016
MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis
Yanlin Su, Jie Xiong, Jinyue Hu, et al.
Frontiers in Oncology
|
August 18, 2022
LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
Min Ling, Qing Liu, Yufei Wang, et al.
European Journal of Pharmacology
|
April 13, 2024
Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers
Yufei Wang, Guihua Wang, Wei Xiang, et al.
Inflammation
|
September 30, 2010
TLR4 activation induces nontolerant inflammatory response in endothelial cells
Wenmeng Wang, Minjie Deng, Xueting Liu, et al.
Plos One
|
February 4, 2014
A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells
Jinyue Hu, Guihua Wang, Xueting Liu, et al.
Page
of 8